Allergan, is a multi-specialty health care company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to live good life.
Type
Public
HQ
Dublin, IE
Founded
1948
Size (employees)
16,700 (est)-46%
Allergan was founded in 1948 and is headquartered in Dublin, IE
Report incorrect company information

Key People/Management at Allergan

Brenton Saunders

Brenton Saunders

Chairman, President and CEO, Allergan
William Meury

William Meury

EVP & Chief Commercial Officer
Maria Hilado

Maria Hilado

EVP & Chief Financial Officer
A. Bailey

A. Bailey

EVP & Chief Legal Officer and Corporate Secretary
Karen Ling

Karen Ling

EVP & Chief Human Resources Officer
C. Nicholson

C. Nicholson

EVP & Chief R&D Officer
Alex Kelly

Alex Kelly

EVP & Chief Communications Officer
Wayne Swanton

Wayne Swanton

Executive Vice President, Global Operations

Allergan Office Locations

Allergan has an office in Parsippany-Troy Hills and Dublin
Parsippany-Troy Hills, US
400 Interpace Pkwy
Show all (2)
Report incorrect company information

Allergan Financials and Metrics

Allergan Financials

Market capitalization (2-Oct-2017)

59.3 b

Closing share price (2-Oct-2017)

178.6

Cash (2-Feb-2018)

4.9 b

EV

56.5 b
Allergan's current market capitalization is $59.3 b.
USDFY, 2013FY, 2014

Cash

3 b4.9 b

Accounts Receivable

883.3 m914.5 m

Inventories

285.3 m296 m

Current Assets

5.3 b6.9 b
USDFY, 2013FY, 2014

Net Income

988.7 m1.5 b

Depreciation and Amortization

254.6 m248.1 m

Inventories

(27 m)(44 m)

Accounts Payable

37.4 m1.9 m
Y, 2014

EV/CFO

29.3 x

Debt/Equity

0.3 x

Debt/Assets

0.2 x

Financial Leverage

1.6 x
Show all financial metrics

Allergan Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Elastagen February 07, 2018$95 m
ZELTIQ Aesthetics (CoolSculpting) February 15, 2017$2.48 b
Report incorrect company information

Allergan News and Updates

Facial Wrinkle Treatment Market: Future Market Projections for Forthcoming years

The facial wrinkle treatment market is expected to show exponential growth over the forecast period owing to rising number of injectable minimally invasive aesthetic surgeries. Posted via Industry Today. Follow us on Twitter @IndustryToday

Beat you to it, Purdue. Other opioid makers already ditched promotions

While the news that Purdue Pharma plans to stop marketing opioids made a media splash this week, other opioid makers already quit. Endo, Teva, Allergan and Johnson & Johnson had all stopped marketing opioids before Purdue made the move.

No new patients for Allergan's fibroid drug Esmya, EMA advises amid liver-damage probe

European regulators have been investigating the safety of Allergan’s Esmya since December, and now they’re advising that no new patients start taking the drug until they wrap up their probe. And meanwhile? The drug is under review for FDA approval.

Memory Impairment Market Key Players – Dart NeuroScience LLC, Allergan Plc, Orexo AB, Radiant Research, Inc., Pfizer Inc. and Catalyst Biosciences, Inc. Analysis and Forecast to 2022

WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Memory Impairment Global Clinical Trials Review, H2, 2018” Posted via Industry Today. Follow us on Twitter @IndustryToday

Botox 2018 Global Market Key Players – Allergan, Ipsen, US World Meds -Analysis And Forecast To 2025

Wiseguyreports.Com Adds “Botox – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Allergan roasts fad fat-fighting techniques in new 'Not Cool vs. Cool' campaign

Those over-the-top, fad techniques for tackling stubborn body fat? Not cool, Allergan says. And it’s got an alternative.
Show more
Report incorrect company information